GlaxoSmithKline Stops Work on Drug for Chronic Cough After Underwhelming Trial Results
A GlaxoSmithKline plant in Montrose, Scotland, on Oct. 22, 2018. Andy Buchanan/Pool via Reuters GlaxoSmithKline on July 17 said it was halting development of a drug that was aimed at treating chronic cough. The company, known as GSK, ran two phase three clinical trials evaluating the drug camlipixant. In one trial, recipients taking 50 milligrams … Read more